nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—BCHE—Cisplatin—urinary bladder cancer	0.696	1	CbGbCtD
Pralidoxime—Drowsiness—Mitomycin—urinary bladder cancer	0.0124	0.0408	CcSEcCtD
Pralidoxime—Inflammation—Fluorouracil—urinary bladder cancer	0.00951	0.0313	CcSEcCtD
Pralidoxime—Vision blurred—Mitomycin—urinary bladder cancer	0.00914	0.0301	CcSEcCtD
Pralidoxime—Pain—Carboplatin—urinary bladder cancer	0.0091	0.0299	CcSEcCtD
Pralidoxime—Inflammation—Etoposide—urinary bladder cancer	0.00826	0.0272	CcSEcCtD
Pralidoxime—Dizziness—Valrubicin—urinary bladder cancer	0.0076	0.025	CcSEcCtD
Pralidoxime—Headache—Valrubicin—urinary bladder cancer	0.0072	0.0237	CcSEcCtD
Pralidoxime—Somnolence—Mitomycin—urinary bladder cancer	0.00704	0.0232	CcSEcCtD
Pralidoxime—Nausea—Valrubicin—urinary bladder cancer	0.00682	0.0225	CcSEcCtD
Pralidoxime—Pain—Mitomycin—urinary bladder cancer	0.00677	0.0223	CcSEcCtD
Pralidoxime—Hyperventilation—Epirubicin—urinary bladder cancer	0.00653	0.0215	CcSEcCtD
Pralidoxime—Hyperventilation—Doxorubicin—urinary bladder cancer	0.00604	0.0199	CcSEcCtD
Pralidoxime—Muscular weakness—Fluorouracil—urinary bladder cancer	0.00591	0.0194	CcSEcCtD
Pralidoxime—Haemoglobin—Thiotepa—urinary bladder cancer	0.00563	0.0185	CcSEcCtD
Pralidoxime—Haemorrhage—Thiotepa—urinary bladder cancer	0.0056	0.0184	CcSEcCtD
Pralidoxime—Dizziness—Mitomycin—urinary bladder cancer	0.00523	0.0172	CcSEcCtD
Pralidoxime—Headache—Mitomycin—urinary bladder cancer	0.00496	0.0163	CcSEcCtD
Pralidoxime—Inflammation—Methotrexate—urinary bladder cancer	0.00495	0.0163	CcSEcCtD
Pralidoxime—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00474	0.0156	CcSEcCtD
Pralidoxime—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00471	0.0155	CcSEcCtD
Pralidoxime—Nausea—Mitomycin—urinary bladder cancer	0.0047	0.0155	CcSEcCtD
Pralidoxime—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00466	0.0153	CcSEcCtD
Pralidoxime—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00463	0.0152	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—urinary bladder cancer	0.00463	0.0152	CcSEcCtD
Pralidoxime—Vision blurred—Thiotepa—urinary bladder cancer	0.0046	0.0151	CcSEcCtD
Pralidoxime—Agitation—Thiotepa—urinary bladder cancer	0.00448	0.0147	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—urinary bladder cancer	0.00429	0.0141	CcSEcCtD
Pralidoxime—Tachycardia—Thiotepa—urinary bladder cancer	0.00388	0.0128	CcSEcCtD
Pralidoxime—Vision blurred—Fluorouracil—urinary bladder cancer	0.0038	0.0125	CcSEcCtD
Pralidoxime—Vision blurred—Cisplatin—urinary bladder cancer	0.0036	0.0119	CcSEcCtD
Pralidoxime—Somnolence—Thiotepa—urinary bladder cancer	0.00354	0.0116	CcSEcCtD
Pralidoxime—Pain—Thiotepa—urinary bladder cancer	0.0034	0.0112	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—urinary bladder cancer	0.00326	0.0107	CcSEcCtD
Pralidoxime—Tachycardia—Fluorouracil—urinary bladder cancer	0.00321	0.0106	CcSEcCtD
Pralidoxime—Tachycardia—Cisplatin—urinary bladder cancer	0.00305	0.01	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—urinary bladder cancer	0.00302	0.00993	CcSEcCtD
Pralidoxime—Somnolence—Gemcitabine—urinary bladder cancer	0.00298	0.00979	CcSEcCtD
Pralidoxime—Somnolence—Fluorouracil—urinary bladder cancer	0.00293	0.00963	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—urinary bladder cancer	0.00288	0.00946	CcSEcCtD
Pralidoxime—Pain—Gemcitabine—urinary bladder cancer	0.00286	0.00942	CcSEcCtD
Pralidoxime—Pain—Fluorouracil—urinary bladder cancer	0.00282	0.00926	CcSEcCtD
Pralidoxime—Tachycardia—Etoposide—urinary bladder cancer	0.00279	0.00918	CcSEcCtD
Pralidoxime—Drowsiness—Methotrexate—urinary bladder cancer	0.00269	0.00883	CcSEcCtD
Pralidoxime—Pain—Cisplatin—urinary bladder cancer	0.00267	0.00878	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00266	0.00876	CcSEcCtD
Pralidoxime—Dizziness—Thiotepa—urinary bladder cancer	0.00263	0.00866	CcSEcCtD
Pralidoxime—Somnolence—Etoposide—urinary bladder cancer	0.00254	0.00836	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—urinary bladder cancer	0.00251	0.00827	CcSEcCtD
Pralidoxime—Headache—Thiotepa—urinary bladder cancer	0.00249	0.0082	CcSEcCtD
Pralidoxime—Pain—Etoposide—urinary bladder cancer	0.00245	0.00804	CcSEcCtD
Pralidoxime—Haemoglobin—Methotrexate—urinary bladder cancer	0.00242	0.00797	CcSEcCtD
Pralidoxime—Haemorrhage—Methotrexate—urinary bladder cancer	0.00241	0.00793	CcSEcCtD
Pralidoxime—Nausea—Thiotepa—urinary bladder cancer	0.00236	0.00778	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—urinary bladder cancer	0.00233	0.00765	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—urinary bladder cancer	0.00227	0.00746	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—urinary bladder cancer	0.00226	0.00742	CcSEcCtD
Pralidoxime—Dizziness—Fluorouracil—urinary bladder cancer	0.00218	0.00716	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—urinary bladder cancer	0.0021	0.0069	CcSEcCtD
Pralidoxime—Headache—Gemcitabine—urinary bladder cancer	0.0021	0.0069	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00209	0.00687	CcSEcCtD
Pralidoxime—Headache—Fluorouracil—urinary bladder cancer	0.00206	0.00679	CcSEcCtD
Pralidoxime—Nausea—Gemcitabine—urinary bladder cancer	0.00199	0.00654	CcSEcCtD
Pralidoxime—Vision blurred—Methotrexate—urinary bladder cancer	0.00198	0.00651	CcSEcCtD
Pralidoxime—Nausea—Fluorouracil—urinary bladder cancer	0.00196	0.00643	CcSEcCtD
Pralidoxime—Dizziness—Etoposide—urinary bladder cancer	0.00189	0.00622	CcSEcCtD
Pralidoxime—Nausea—Cisplatin—urinary bladder cancer	0.00185	0.0061	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—urinary bladder cancer	0.00185	0.00609	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—urinary bladder cancer	0.0018	0.00594	CcSEcCtD
Pralidoxime—Headache—Etoposide—urinary bladder cancer	0.00179	0.00589	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—urinary bladder cancer	0.00171	0.00563	CcSEcCtD
Pralidoxime—Nausea—Etoposide—urinary bladder cancer	0.0017	0.00559	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—urinary bladder cancer	0.00167	0.00549	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—urinary bladder cancer	0.00156	0.00515	CcSEcCtD
Pralidoxime—Somnolence—Methotrexate—urinary bladder cancer	0.00152	0.00501	CcSEcCtD
Pralidoxime—Pain—Methotrexate—urinary bladder cancer	0.00146	0.00482	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—urinary bladder cancer	0.00145	0.00476	CcSEcCtD
Pralidoxime—Somnolence—Epirubicin—urinary bladder cancer	0.00142	0.00469	CcSEcCtD
Pralidoxime—Pain—Epirubicin—urinary bladder cancer	0.00137	0.00451	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—urinary bladder cancer	0.00132	0.00434	CcSEcCtD
Pralidoxime—Pain—Doxorubicin—urinary bladder cancer	0.00127	0.00417	CcSEcCtD
Pralidoxime—Dizziness—Methotrexate—urinary bladder cancer	0.00113	0.00373	CcSEcCtD
Pralidoxime—Headache—Methotrexate—urinary bladder cancer	0.00107	0.00353	CcSEcCtD
Pralidoxime—Dizziness—Epirubicin—urinary bladder cancer	0.00106	0.00349	CcSEcCtD
Pralidoxime—Nausea—Methotrexate—urinary bladder cancer	0.00102	0.00335	CcSEcCtD
Pralidoxime—Headache—Epirubicin—urinary bladder cancer	0.001	0.0033	CcSEcCtD
Pralidoxime—Dizziness—Doxorubicin—urinary bladder cancer	0.000981	0.00323	CcSEcCtD
Pralidoxime—Nausea—Epirubicin—urinary bladder cancer	0.000952	0.00313	CcSEcCtD
Pralidoxime—Headache—Doxorubicin—urinary bladder cancer	0.000929	0.00306	CcSEcCtD
Pralidoxime—Nausea—Doxorubicin—urinary bladder cancer	0.000881	0.0029	CcSEcCtD
